Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treprostinil”

35 pharma patents match "treprostinil" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 35
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 35 pharmaceutical patents matching "treprostinil" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

35 results for “treprostinil” · 30,257 patents in full index Clear search

  1. US 12357599

    Prodrugs of treprostinil

    United Therapeutics Corporation · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  2. US 12173021

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  3. US 12168071

    Treprostinil derivatives and their use in pharmaceutical compositions

    United Therapeutics Corporation · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  4. US 11826328

    Stable treprostinil prodrugs

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  5. US 11723887

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  6. US 11672775

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  7. US 11634443

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  8. US 11571444

    Enhancement of MSC immunomodulatory properties by treprostinil

    United Therapeutics Corporation · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  9. US 11357782

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  10. US 11236035

    Salts of treprostinil

    United Therapeutics Corporation · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  11. US 10716793

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  12. US 10695308

    Inhalation formulations of treprostinil

    United Therapeutics Corporation · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  13. US 10548863

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  14. US 10478410

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  15. US 10376525

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  16. US 10322099

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  17. US 10167247

    Solid forms of treprostinil

    United Therapeutics Corporation · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted
  18. US 10076505

    Inhalation formulations of Treprostinil

    United Therapeutics Corporation · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  19. US 9988334

    Salts of treprostinil

    United Therapeutics Corporation · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  20. US 9822057

    Solid forms of treprostinil

    United Therapeutics Corporation · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  21. US 9713599

    Parenteral formulations of treprostinil

    United Therapeutics Corporation · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted
  22. US 9701611

    Salts of treprostinil

    United Therapeutics Corporation · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  23. US 9604901

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  24. US 9593066

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted